BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Apr 25, 2011
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Seattle Genetics preclinical data

In a mouse xenograft model of breast cancer, Seattle Genetics' anti-LIV-1 antibody-drug conjugate (ADC) significantly delayed tumor growth vs. untreated...

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >